About this trial
Vaginal laser together with the use of moisturizing and repairing gels could be an effective therapy for the treatment of genitourinary syndrome in women with a history of neoplasia in whom the use of estrogens is not recommended.
The purpose of this study is to evaluate the effectiveness of vaginal laser together with adjuvant treatment with a hydrating and repairing niosomal gel as a beneficial treatment in this group of patients.
Eligibility criteria
Qualifiers
Patients with an established SGM diagnosis.
Patients with a history of neoplasia in whom the use of estrogens as the first alternative for the treatment of GMS is not recommended.
Disqualifiers
Patients with concomitant vulvovaginal pathology.
Patients with a diagnosis of pelvic organ prolapse grade II or greater.
Trial design
Treatments tested in this trial
- CO2 laser
Treatment groups
Locations
1Sponsors and collaborators
Hospital Universitari de Bellvitge
Lead sponsor